89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in 89bio, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- +1 vs. Q2 2024
- Shares held
- 104.5M
- +8.12M (+8.4%) vs. Q2 2024
- Total value
- $773.8M
- +$1.65M (+0.2%) vs. Q2 2024
- New holders
- 17
- 66 more added
- Sold out
- 16
- 39 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $1.11M |
| Q3 2025 | 198 | $2.27B |
| Q2 2025 | 185 | $1.58B |
| Q1 2025 | 187 | $1.14B |
| Q4 2024 | 156 | $948.7M |
| Q3 2024 | 144 | $773.8M |
| Q2 2024 | 145 | $828.4M |
| Q1 2024 | 150 | $1.14B |
| Q4 2023 | 153 | $1.05B |
| Q3 2023 | 160 | $1.11B |
| Q2 2023 | 157 | $1.46B |
| Q1 2023 | 147 | $1.08B |
| Q4 2022 | 106 | $589.5M |
| Q3 2022 | 86 | $227.3M |
| Q2 2022 | 70 | $104.6M |
| Q1 2022 | 69 | $64.3M |
| Q4 2021 | 50 | $226.1M |
| Q3 2021 | 48 | $339.4M |
| Q2 2021 | 49 | $315.2M |
| Q1 2021 | 67 | $400.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 241,504 | $1.79M | 0.00% | +115,448+91.6% | Added |
| Caption Management, LLC | 255,200 | $1.89M | 0.20% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 289,912 | $2.15M | 0.00% | +6,811+2.4% | Added |
| Exome Asset Management LLC | 300,600 | $2.22M | 1.50% | +300,600 | New |
| Renaissance Technologies LLC | 312,024 | $2.31M | 0.00% | +32,624+11.7% | Added |
| Wellington Management Group LLP | 319,045 | $2.36M | 0.00% | −38,491−10.8% | Reduced |
| Bank of America Corp | 325,707 | $2.41M | 0.00% | −662−0.2% | Reduced |
| MPM Oncology Impact Management LP | 330,000 | $2.44M | 0.37% | −791,736−70.6% | Reduced |
| Susquehanna International Group, LLP | 340,071 | $2.52M | 0.00% | +30,655+9.9% | Added |
| Two Sigma Investments, LP | 368,688 | $2.73M | 0.01% | −165,029−30.9% | Reduced |
| Millennium Management LLC | 381,981 | $2.83M | 0.00% | −628,371−62.2% | Reduced |
| Morgan Stanley | 400,238 | $2.96M | 0.00% | +107,793+36.9% | Added |
| Walleye Capital LLC | 435,298 | $3.22M | 0.03% | +402,624+1,232.2% | Added |
| Standard Life Aberdeen plc | 470,387 | $3.48M | 0.01% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 500,000 | $3.70M | 0.44% | +50,000+11.1% | Added |
| Sphera Funds Management Ltd. | 536,547 | $3.97M | 0.65% | +10,000+1.9% | Added |
| Franklin Resources Inc | 504,563 | $3.99M | 0.00% | −327,657−39.4% | Reduced |
| Alliancebernstein L.P. | 587,062 | $4.34M | 0.00% | +30,535+5.5% | Added |
| Superstring Capital Management LP | 595,203 | $4.40M | 3.94% | −85,200−12.5% | Reduced |
| Charles Schwab Investment Management Inc | 721,050 | $5.34M | 0.00% | +53,932+8.1% | Added |
| University of Wisconsin Foundation | 724,132 | $5.36M | 3.50% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 733,497 | $5.43M | 0.00% | −171,320−18.9% | Reduced |
| Erste Asset Management GmbH | 763,000 | $5.63M | 0.07% | +40,000+5.5% | Added |
| Northern Trust Corp | 794,712 | $5.88M | 0.00% | +70,848+9.8% | Added |
| Alyeska Investment Group, L.P. | 808,564 | $5.98M | 0.03% | +8,564+1.1% | Added |
| Laurion Capital Management LP | 810,533 | $6.00M | 0.38% | −1,370,398−62.8% | Reduced |
| Candriam Luxembourg S.C.A. | 848,079 | $6.28M | 0.04% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 871,404 | $6.45M | 0.07% | +412,174+89.8% | Added |
| Adage Capital Partners GP, L.L.C. | 875,000 | $6.47M | 0.01% | +475,000+118.8% | Added |
| Frazier Life Sciences Management, L.P. | 1,000,000 | $7.40M | 0.30% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,569,850 | $11.6M | 0.68% | −175,806−10.1% | Reduced |
| Geode Capital Management, LLC | 2,074,970 | $15.4M | 0.00% | +160,356+8.4% | Added |
| Citadel Advisors LLC | 2,556,727 | $18.9M | 0.02% | +447,645+21.2% | Added |
| Deep Track Capital, LP | 2,766,512 | $20.5M | 0.65% | +472,501+20.6% | Added |
| Westfield Capital Management Co LP | 3,006,038 | $22.2M | 0.10% | +686,673+29.6% | Added |
| Pictet Asset Management Holding SA | 3,246,608 | $24.0M | 0.03% | −355,977−9.9% | Reduced |
| State Street Corp | 3,251,687 | $24.1M | 0.00% | +7,184+0.2% | Added |
| Vanguard Group Inc | 5,006,277 | $37.0M | 0.00% | +201,324+4.2% | Added |
| BVF Inc | 6,811,631 | $50.4M | 1.47% | −756,848−10.0% | Reduced |
| RTW Investments, LP | 7,378,548 | $54.6M | 0.79% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,549,302 | $55.9M | 0.00% | +7,549,302 | New |
| Suvretta Capital Management, LLC | 7,991,644 | $59.1M | 2.12% | −40,201−0.5% | Reduced |
| Ra Capital Management, L.P. | 14,175,398 | $104.9M | 1.21% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 15,158,218 | $112.1M | 0.06% | +1,882,108+14.2% | Added |
| Braidwell LP | 0 | $0 | 0.00% | −164,227−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −98,597−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −59,202−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −44,500−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −40,656−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −40,488−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −31,978−100.0% | Sold out |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −28,658−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −27,604−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −24,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −24,088−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,788−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −11,374−100.0% | Sold out |
| Wetzel Investment Advisors, Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −816−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Institutional & Family Asset Management, LLC | – | – | – | – | Not filed |